Niuvanniemen sairaala

Julkaisut
Publications

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Taipale H, Tanskanen A, Mehtälä J, Vattulainen P, Correll CU, Tiihonen J. 20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20). World Psychiatry 2020:19(1):61-68.
2 Tiihonen J, Tanskanen A, Taipale H. 20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia. Am J Psychiatry 2018:175(8):765-773.
3 Kupila J, Kärkkäinen O, Laukkanen V, Häkkinen M, Kautiainen H, Tiihonen J, Storvik M. (3H)Ifenprodil binding in post-mortem brains of cloninger type 1 and 2 alcoholics: A whole-hemisphere autoradiography study . Psychiatry Res 2015:231(3):197-201.
4 Koponen M, Lavikainen P, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A. Accumulation of Hospital Days Among Antipsychotic Initiators With Alzheimer's Disease. J Am Med Dir Assoc 2019:20(12):1488-1494.e3.
5 Terevnikov V, Stenberg J, Tiihonen J, Burkin M, Joffe G. Add-on mirtazapine improves orgasmic functioning in patients with schizophrenia treated with first-generation antipsychotics. Nord J Psychiatry 2017:71(1):77-80.
6 Lintunen J, Lähteenvuo M, Tiihonen J, Tanskanen A, Taipale H. Adenosine modulators and calcium channel blockers as add-on treatment for schizophrenia. NPJ Schizophr 2021:7(1):1.
7 Forsman J, Taipale H, Masterman T, Tiihonen J, Tanskanen A. Adherence to psychotropic medication in completed suicide in Sweden 2006-2013: a forensic-toxicological matched case-control study. Eur J Clin Pharmacol 2019:75(10):1421-1430.
8 Taipale H, Tanskanen A, Koponen M, Tolppanen AM, Tiihonen J, Hartikainen S. Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older persons. Clin Epidemiol 2016:8:363-371.
9 Lindsberg PJ, Castrén E, ..., Isometsä E, Kalso E, Marttunen M, Pihko H, Tienari P, Wartiovaara A, Jäkälä P, Kälviäinen R, Soininen H, Tiihonen J, Karlsson H, Rinne J, Roine RO, Elovaara I, Tamminen T, Öhman J, Majamaa K, Hari R. Aivosairaudet ovat kalleimmat kansantautimme. Duodecim 2014:130(17):1721-30.
10 Lehikoinen AI, Kärkkäinen OK, Lehtonen MAS, Auriola SOK, Hanhineva KJ, Heinonen ST. Alcohol and substance use are associated with altered metabolome in the first trimester serum samples of pregnant mothers . Eur J Obstet Gynecol Reprod Biol 2018:223:79-84.
11 Laukkanen V, Laukkanen V. Alterations in the neurotransmitter receptor binding densities in cloninger type 1 and 2 alcoholics. Doctoral dissertation. Kuopio: University of Eastern Finland, 2016. Publications of the University of Eastern Finland. Dissertations in Health Sciences 355. 76 p.
12 Taipale H, Tolppanen A-M, Purhonen M, Tanskanen A, Ahonen R, Tiihonen J, Hartikainen S. Alueelliset erot sairaalapäivissä ja lääkekustannuksissa Alzheimerin tautia sairastavilla ja verokeilla. Suomen Lääkärilehti 2016:71(22):1613-1619.
13 Juhola L, Taipale H, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A-M. Alzheimer-potilaat ja psyykenlääkkeiden käyttö 2005-2011. Suomen Lääkärilehti 2019:74(10):609-616.
14 Kärkkäinen O, Kupila J, Häkkinen M, Laukkanen V, Tupala E, Kautiainen H, Tiihonen J, Storvik M. AMPA receptors in post-mortem brains of Cloninger type 1 and 2 alcoholics: A whole-hemisphere autoradiography study. Psychiatry Res Neuroimaging 2013:214:429-434.
15 Kivimies K. Amphetamine, Cannabis and Opioid Use Disorders in Forensic Patients and in Schizophrenia. Doctoral dissertation. Kuopio: University of Eastern Finland, 2018. Publications of the University of Eastern Finland. Dissertations in Health Sciences 468. 52 p.
16 Lindner P, Flodin P, Larm P, Budhiraja M, Savic-Berglund I, Jokinen J, Tiihonen J, Hodgins S. Amygdala-orbitofrontal structural and functional connectivity in females with anxiety disorders, with and without a history of conduct disorder. Sci Rep 2018:8(1):1101.
17 Lampela P, Tolppanen AM, Tanskanen A, Tiihonen J, Hartikainen S, Taipale H. Anticholinergic Exposure and Risk of Pneumonia in Persons with Alzheimer's Disease: A Nested Case-Control Study. J Alzheimer Dis 2017:56(1):119-128.
18 Taipale H1, Tanskanen A, Koponen M, Tolppanen AM, Tiihonen J, Hartikainen S. Antidementia drug use among community-dwelling individuals with Alzheimer's disease in Finland: a nationwide register-based study. Int Clin Psychopharmacol 2014:29(4):216-23.
19 Torvinen-Kiiskinen S, Tolppanen AM, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Taipale H. Antidepressant use and risk of hip fractures among community-dwelling persons with and without Alzheimer's disease. Int J Geriatr Psychiatry 2017:32(12):e107-e115.
20 Sarycheva T, Lavikainen P, Taipale H, Tiihonen J, Tanskanen A, Hartikainen S, Tolppanen A. Antiepileptic drug use and mortality among community-dwelling persons with Alzheimer disease. Neurology 2020:94(20):e2099-e2108.
21 Sarycheva T, Lavikainen P, Taipale H, Tiihonen J, Tanskanen A, Hartikainen S, Tolppanen A-M. Antiepileptic Drug Use and the Risk of Stroke Among Community-Dwelling People With Alzheimer Disease: A Matched Cohort Study. J Am Heart Assoc 2018:7(18):e009742.
22 Taipale H, Lampela P, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A. Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study. J Alzheimer Dis 2019:68(1):127-136.
23 Lavikainen P, Taipale H, Tanskanen A, Koponen M, Tiihonen J, Hartikainen S, Tolppanen A. Antiepileptic Drugs and Accumulation of Hospital Days Among Persons With Alzheimer's Disease. J Am Med Dir Assoc 2019:20(6):751-758.
24 Luykx JJ, Tiihonen J. Antipsychotic discontinuation: mind the patient and the real-world evidence. Lancet Psychiat 2021:8(7):555-557.
25 Taipale H1, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S. Antipsychotic doses among community-dwelling persons with Alzheimer disease in Finland. J Clin Psychopharmacol 2014:34(3):435-40.
26 Taipale H1, Koponen M1, Tanskanen A2, Tolppanen AM3, Tiihonen J, Hartikainen S. Antipsychotic Polypharmacy among a Nationwide Sample of Community-Dwelling Persons with Alzheimer's Disease. J Alzheimer Dis 2014:41(4):1223-8.
27 Torniainen M, Mittendorfer-Rutz E, Tanskanen A, Björkenstam C, Suvisaari J, Alexanderson K, Tiihonen J. Antipsychotic Treatment and Mortality in Schizophrenia. Schizophr Bull 2015:41(3):656-63.
28 Tolppanen AM, Koponen M, Tanskanen A, Lavikainen P, Sund R, Tiihonen J, Hartikainen S, Taipale H. Antipsychotic Use and Risk of Hospitalization or Death Due to Pneumonia in Persons With and Those Without Alzheimer Disease. Chest 2016:150(6):1233-1241.
29 Koponen M, Taipale H, Lavikainen P, Tanskanen A, Tiihonen J, Tolppanen A, Ahonen R, Hartikainen S. Antipsychotic Use and the Risk of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease. J Clin Psychiatry 2017:78(3):e257-e263.
30 Orsel K, Taipale H, Raatikainen S, Lampela P, Tolppanen A-M, Koponen M, Tanskanen A, Tiihonen J, Gardarsdottir H, Hartikainen S. Antipsychotic Use and the Risk of Initiating Medication for Benign Prostate Hyperplasia in Persons With Alzheimer Disease: A Matched Cohort Study. J Clin Psychopharmacol 2018:38(5):494-497.
31 Taipale H, Mittendorfer-Rutz E, Alexanderson K, Majak M, Mehtälä J, Hoti F, Jedenius E, Enkusson D, Leval A, Sermon J, Tanskanen A, Tiihonen J. Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia. Schizophr Res 2018:197:274-280.
32 Husso M, Sipola P, Kuittinen T, Manninen H, Vainio P, Hartikainen J, Saarakkala S, Töyräs J, Kuikka J. Assessment of myocardial perfusion with MRI using a modified dual bolus method. Physiol Meas 2014:35(4):533-547.
33 Olubamwo O, Onyeka IN, Aregbesola A, Ronkainen K, Tiihonen J, Föhr J, Kauhanen J. Association between route of illicit drug administration and hospitalizations for infective endocarditis. SAGE Open Med 2017:5:2050312117740987.
34 Onyeka IN, Basnet S, Beynon CM, Tiihonen J, Tiihonen J, Föhr J, Kauhanen J. Association between routes of drug administration and all-cause mortality among drug users. J Subst Use 2016:21(6):559-565.
35 Tiihonen J, Halonen P, Tiihonen L, Kautiainen H, Storvik M, Callaway J. The association of ambient temperature and violent crime. Sci Rep 2017:7(1):6543.
36 Tiihonen J, Taipale H, Mehtälä J, Vattulainen P, Correll CU, Tanskanen A. Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia. JAMA Psychiatry 2019:76(5):499-507.
37 Tarvainen A, Hartikainen S, Taipale H, Tanskanen A, Koponen M, Tolppanen AM. Association of recent hospitalisation with antidepressant initiation among community dwellers with Alzheimer's disease. Int J Geriatr Psychiatry 2021:36(7):1075-1084.
38 Mittendorfer-Rutz E, Härkänen T, Tiihonen J, Haukka J. Association of Socio-Demographic Factors, Sick-Leave and Health Care Patterns with the Risk of Being Granted a Disability Pension among Psychiatric Outpatients with Depression. PLoS ONE 2014:9(6):e99869.
39 Bendre M, Comasco E, Checknita D, Tiihonen J, Hodgins S, Nilsson KW. Associations between MAOA-uVNTR genotype, maltreatment, MAOA methylation, and alcohol consumption in young adult males. Alcohol Clin Exp Res 2018:42(3):508-519.
40 Checknita D, Ekström TJ, Comasco E, Nilsson KW, Tiihonen J, Hodgins S. Associations of monoamine oxidase A gene first exon methylation with sexual abuse and current depression in women. J Neural Transm 2018:125(7):1053-1064.
41 Lindner P, Flodin P, Budhiraja M, Savic I, Jokinen J, Tiihonen J, Hodgins S. Associations of Psychopathic Traits With Local and Global Brain Network Topology in Young Adult Women. Biol Psychiatry Cogn Neurosci Neuroimaging 2018:3(12):1003-1012.
42 Lampela P, Tolppanen A, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Taipale H. Asthma and Chronic Obstructive Pulmonary Disease as a Comorbidity and Association with the Choice of Antidementia Medication Among Persons with Alzheimer's Disease. J Alzheimer Dis 2020:73(3):1243-1251.
43 Boccardi M, Bocchetta M, Aronen HJ, Repo-Tiihonen E, Vaurio O, Thompson PM, Tiihonen J, Frisoni GB. Atypical nucleus accumbens morphology in psychopathy: Another limbic piece in the puzzle. Int J Law Psychiatry 2013:36:157-167.
44 Ojala KP, Tiihonen J, Repo-Tiihonen E, Tikkanen R, Virkkunen M. Basal insulin secretion, PCL-R and recidivism among impulsive violent alcoholic offenders. Psychiatry Res 2015:225(3):420-4.
45 Joensuu M, Ahola P, Knekt P, Lindfors O, Saarinen P, Tolmunen T, Valkonen-Korhonen M, Vanninen R, Jääskeläinen T, Virtala E, Kuikka J, Tiihonen J, Lehtonen J. Baseline symptom severity predicts serotonin transporter change during psychotherapy in patients with major depression. Psychiatry Clin Neurosci 2016:70(1):34-41.
46 Taipale H, Särkilä H, Tanskanen A, Kurko T, Taiminen T, Tiihonen J, Sund R, Tuulio-henriksson A, Saastamoinen L, Hietala J:. Bentsodiatsepiinien käyttö pitkäaikaistuu yli kolmasosalla aloittajista. Duodecim 2021:137(1):103.
47 Kurko T, Saastamoinen L, Tuulio-Henriksson A, Taiminen T, Tiihonen J, Airaksinen M, Hietala J. Bentsodiatsepiinien pitkäaikaiskäyttö on vähentynyt. Suomen Lääkärilehti 2018:73(20):1292-1299.
48 Budhiraja M, Savic I, Lindner P, Jokinen J, Tiihonen J, Hodgins S. Brain structure abnormalities in young women who presented conduct disorder in childhood/adolescence. Cogn Affect Behav Neurosci 2017:17(4):869-885.
49 Mittendorfer-Rutz E, Rahman S, Tanskanen A, Majak M, Mehtälä J, Hoti F, Jedenius E, Enkusson D, Leval A, Sermon J, Taipale H, Tiihonen J. Burden for Parents of Patients With Schizophrenia-A Nationwide Comparative Study of Parents of Offspring With Rheumatoid Arthritis, Multiple Sclerosis, Epilepsy, and Healthy Controls. Schizophr Bull 2019:45(4):794-803.
50 Solje E, Hartikainen P, Valori M, Vanninen R, Tiihonen J, Hakola P, Tienari PJ, Remes AM. The C9ORF72 expansion does not affect the phenotype in Nasu-Hakola disease with the DAP12 mutation. Neurobiol Aging 2014:35(7):1780e13-7.
51 Tolppanen A, Taipale H, Koponen M, Tiihonen J, Hartikainen S. Causes of death in a nationwide cohort of community-dwellers with Alzheimer's disease. BMC Geriatrics 2020:20(1):441.
52 Ojansuu I, Ojansuu I, Putkonen H, Tiihonen J. Cause-specific mortality in Finnish forensic psychiatric patients. Nord J Psychiatry 2018:72(5):374-379.
53 Toivonen P, Könönen M, Niskanen E, Vaurio O, Repo-Tiihonen E, Seppänen A, Aronen HJ, Vanninen R, Tiihonen J, Laakso M. Cavum septum pellucidum and psychopathy. Br J Psychiatry 2013(203):152-153.
54 Kuosmanen A, Tiihonen J, Repo-Tiihonen E, Eronen M, Turunen H. Changes in patient safety culture: A patient safety intervention for Finnish forensic psychiatric hospital staff. J Nurs Manag 2019:27(4):848-857.
55 Heikkinen N, Kärkkäinen O, Laukkanen E, Kekkonen V, Kaarre O, Kivimäki P, Könönen M, Velagapudi V, Nandania J, Lehto SM, Niskanen E, Vanninen R, Tolmunen T. Changes in the serum metabolite profile correlate with decreased brain gray matter volume in moderate-to-heavy drinking young adults. Alcohol 2019:75:89-97.
56 Basnet S, Onyeka IN, Tiihonen J, Föhr J, Kauhanen J. Characteristics of drug-abusing females with and without children seeking treatment in Helsinki, Finland. Scand J Public Health 2015:43(3):221-8.
57 Sommer IE, Tiihonen J, van Mourik A, Tanskanen A, Taipale H. The clinical course of schizophrenia in women and men-a nation-wide cohort study. NPJ Schizophr 2020:6(1):12.
58 Tiihonen J, Leucht S. Clozapine resistance - Augmentation strategies. Eur Neuropsychopharmacology 2013:23:338.
59 Putkonen A, Kuivalainen S, Louheranta O, Repo-Tiihonen E, Ryynänen OP, Kautiainen H, Tiihonen J. Cluster-randomized controlled trial of reducing seclusion and restraint in secured care of men with schizophrenia. Psychiatr Serv 2013:64(9):850-855.
60 Laukkanen E. Coercive Measures in Finnish Psychiatric Inpatient Care: Special Emphasis on Psychiatric Nursing Managers' Attitudes. Doctoral dissertation. Kuopio: 2021. Publications of the University of Eastern Finland. Dissertations in Health Sciences 608. 110 p. p.
61 Onyeka IN, Beynon CM, Uosukainen H, Korhonen MJ, Ilomäki J, Bell JS, Paasolainen M, Tasa N, Tiihonen J, Kauhanen J. Coexisting social conditions and health problems among clients seeking treatment for illicit drug use in Finland: The HUUTI study. BMC Public Health 2013:13:380.
62 Hallikainen I, Koivisto AM, Paajanen T, Hiltunen A, Karppi P, Vanhanen M, Välimäki T, Herukka S-K, Soininen H, Hänninen T. Cognitive and neuropsychiatric symptom differences in early stages of Alzheimer's Disease: Kuopio ALSOVA Study. Dement Geriatr Cogn Disord 2012:2:209-218.
63 Kuokkanen R, Lappalainen R, Repo-Tiihonen E, Tiihonen J, Aho-Mustonen K. Cognitive insight, clinical insight, and reasoning in schizophrenia: a pilot study in a forensic setting. J Forensic Psychol Pract 2016:16(4):253-267.
64 Tolppanen A, Taipale H, Koponen M, Lavikainen P, Tanskanen A, Tiihonen J, Hartikainen S. Cohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) study. BMJ Open 2016:6(7):e012100.
65 Tiihonen J, Taipale H, Correll CU. Commentary on Robert Whitaker's viewpoint. Psychol Med 2020:50(16):2653-2654.
66 Kivimies K, Repo-Tiihonen E, Kautiainen H, Tiihonen J. Comorbid opioid use is undertreated among forensic patients with schizophrenia. Subst Abuse Treat Prev Policy 2018:13(1):39.
67 Taipale H, Mehtälä J, Tanskanen A, Tiihonen J. Comparative Effectiveness of Antipsychotic Drugs for Rehospitalization in Schizophrenia-A Nationwide Study With 20-Year Follow-up. Schizophr Bull 2018:44(6):1381-1387.
68 Taipale H, Lähteenvuo M, Tanskanen A, Mittendorfer-Rutz E, Tiihonen J. Comparative Effectiveness of Antipsychotics for Risk of Attempted or Completed Suicide Among Persons With Schizophrenia. Schizophr Bull 2021:47(1):23-30.
69 Forsman J, Taipale H, Masterman T, Tiihonen J, Tanskanen A. Comparison of dispensed medications and forensic-toxicological findings to assess pharmacotherapy in the Swedish population 2006 to 2013. Pharmacoepidemiol Drug Saf 2018:27(10):1112-1122.
70 Tolppanen A, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S. Comparison of predictors of hip fracture and mortality after hip fracture in community-dwellers with and without Alzheimer's disease - exposure-matched cohort study. BMC Geriatrics 2016:16(1):204.
71 Moga DC, Taipale H, Tolppanen A-M, Tanskanen A, Tiihonen J, Hartikainen S, Wu Q, Jicha GA, Gnjidic D. A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer's Disease in the US and Finland. Drugs Aging 2017:34(1):55-65.
72 Torvinen-Kiiskinen S, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S. Concomitant use of acetylcholine esterase inhibitors and urinary antispasmodics among Finnish community-dwelling persons with Alzheimer disease. J Clin Psychopharmacol 2014:34(6):722-7.
73 Karttunen N, Taipale H, Hamina A, Tanskanen A, Tiihonen J, Tolppanen A, Hartikainen S. Concomitant use of benzodiazepines and opioids in community-dwelling older people with or without Alzheimer's disease-A nationwide register-based study in Finland. Int J Geriatr Psychiatry 2019:34(2):280-288.
74 Ahola P, Härkänen T, Lehtonen J, Lindfors O, Knekt P, Joensuu M, Saarinen P, Tolmunen T, Virtala E, Tiihonen J, Valkonen-Korhonen M. Concordance and discordance in how patients and therapists experience the psychotherapy process in the treatment of depression. Psychiatr Fenn 2020:51:122-141.
75 Lindner P, Savic I, Sitnikov R, Budhiraja M, Liu Y, Jokinen J, Tiihonen J, Hodgins S. Conduct disorder in females is associated with reduced corpus callosum structural integrity independent of comorbid disorders and exposure to maltreatment. Transl Psychiatry 2016:6:e714.
76 Tiihonen J, Koskuvi M, Lähteenvuo M, Virtanen PL, Ojansuu I, Vaurio O, Gao Y, Hyötyläinen I, Puttonen KA, Repo-Tiihonen E, Paunio T, Rautiainen M, Tyni S, Koistinaho J, Lehtonen S. Correction: Neurobiological roots of psychopathy. Mol Psychiatry 2020:25(12):3455-3456.
77 Budhiraja M, Pereira JB, Lindner P, Westman E, Jokinen J, Savic I, Tiihonen J, Hodgins S. Cortical structure abnormalities in females with conduct disorder prior to age 15. Psychiatry Res Neuroimaging 2019:289:37-44.
78 Laukkanen V, Storvik M, Häkkinen M, Akamine Y, Tupala E, Virkkunen M, Tiihonen J. Decreased GABA(A) benzodiazepine binding site densities in postmortem brains of Cloninger type 1 and 2 alcoholics. Alcohol 2013:47:103-108.
79 Laukkanen V, Laukkanen V, Kärkkäinen O, Kautiainen H, Tiihonen J, Storvik M. Decreased [³H]naloxone Binding in the Dentate Gyrus of Cloninger Type 1 Anxiety-Prone Alcoholics: A Postmortem Whole-Hemisphere Autoradiography Study. Alcohol Clin Exp Res 2015:39(8):1352-9.
80 Kuivalainen S, Vehviläinen-Julkunen K, Louheranta O, Putkonen A, Repo-Tiihonen E, Tiihonen J. De-escalation techniques used, and reasons for seclusion and restraint, in a forensic psychiatric hospital. Int J Ment Health Nurs 2017:26(5):513-524.
81 Suokas JT, Suvisaari JM, Haukka J, Korhonen P, Tiihonen J. Description of long-term polypharmacy among schizophrenia outpatiens. Soc Psychiatry Psychiatr Epidemiol 2013:48:631-638.
82 Braithwaite B, Paananen J, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A. Detection of medications associated with Alzheimer's disease using ensemble methods and cooperative game theory. Int J Med Inf 2020:141:104142.
83 Olubamwo OO, Onyeka IN, Aregbesola A, Ronkainen K, Tiihonen J, Föhr J, Kauhanen J. Determinants of hospitalizations for pneumonia among Finnish drug users. SAGE Open Med 2018:6:2050312118784311.
84 Aregbesola A, Onyeka IN, Olubamwo O, Ronkainen K, Tiihonen J, Föhr J, Kauhanen J. Diabetes hospitalizations and deaths in a cohort of treatment-seeking illicit drug users. SAGE Open Med 2018:6:2050312118768164.
85 Laakso MP, Jukarainen NM, Vepsäläinen J. Diagnosis of dementias by high-field 1H MRS of cerebrospinal fluid. J Neurol Neurosurg Psychiatry 2015:86(12):1286-90.
86 Hamina A, Taipale H, Tanskanen A, Tolppanen A-M, Tiihonen J, Hartikainen S. Differences in analgesic use in community-dwelling persons with and without Alzheimer's disease. Eur J Pain 2017:21(4):658-667.
87 Tanskanen A, Taipale H, Koponen M, Tolppanen AM, Hartikainen S, Ahonen R, Tiihonen J. Drug exposure in register-based research-An expert-opinion based evaluation of methods. PLoS ONE 2017:12(9):e0184070.
88 Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S. Drug use in persons with and without Alzheimer's disease aged 90 years or more. Age Ageing 2016:45(6):900-904.
89 Tanskanen A. Drug Use Modelling Method PRE2DUP. From Prescriptions to Drug Use Periods. Doctoral dissertation. Kuopio: University of Eastern Finland, 2019. Publications of the University of Eastern Finland. Dissertations in Health Sciences 514. 59 p.
90 Kettunen R, Taipale H, Tolppanen A, Tanskanen A, Tiihonen J, Hartikainen S, Koponen M. Duration of new antidepressant use and factors associated with discontinuation among community-dwelling persons with Alzheimer's disease. Eur J Clin Pharmacol 2019:75(3):417-425.
91 Torvinen-Kiiskinen S, Tolppanen A-M, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Taipale H. Editorial: let's take a break from studying the PPI-fracture association-Authors' reply. Editorial. Aliment Pharmacol Ther 2018:47(11):1544-1545.
92 Lähteenvuo M, Taipale H, Tanskanen A, Mittendorfer-Rutz E, Tiihonen J. Effectiveness of pharmacotherapies for delusional disorder in a Swedish national cohort of 9076 patients. Schizophr Res 2021:228:367-372.
93 Tikkanen R, Saukkonen T, Fex M, Bennet H, Rautiainen MR, Paunio T, Koskinen M, Panarsky R, Bevilacqua L, Sjöberg RL, Tiihonen J, Virkkunen M. The effects of a HTR2B stop codon and testosterone on energy metabolism and beta cell function among antisocial Finnish males. J Psychiatric Res 2016:81:79-86.
94 Shen Q, Heikkinen N, Kärkkäinen O, Gröhn H, Könönen M, Liu Y, Kaarre O, Zhang Z, Tan C, Tolmunen T, Vanninen R. Effects of long-term adolescent alcohol consumption on white matter integrity and their correlations with metabolic alterations. Psychiatry Res Neuroimaging 2019:294:111003.
95 Ahola P, Joensuu M, Knekt P, Lindfors O, Saarinen P, Tolmunen T, Valkonen-Korhonen M, Jääskeläinen T, Virtala E, Tiihonen J, Lehtonen J. Effects of Scheduled Waiting for Psychotherapy in Patients With Major Depression. J Nerv Ment Dis 2017:205(8):611-617.
96 Holm M, Taipale H, Tanskanen A, Tiihonen J, Mitterdorfer-rutz E. Employment among people with schizophrenia or bipolar disorder: A population-based study using nationwide registers. Acta Physiol Scand 2021:143(1):61-71.
97 Kärkkäinen OK, Lehtonen M, Laukkanen V, Tupala E, Hyytiä P, Kautiainen H, Tiihonen J, Callaway JC, Storvik M. Endogenous cannabinoids in amygdala and hippocampus in post-mortem brains of Cloninger type 1 and 2 alcoholics. Alcohol 2013:47:399-403.
98 Tiihonen E. Epäsosiaalinen persoonallisuushäiriö. Lääkärin käsikirja - viimeisin muutos 12.4.2013.
99 Repo-Tiihonen E, Hallikainen T. Epäsosiaalinen persoonallisuushäiriö. Duodecim 2016:132(2):130-6.
100 Tiwari AK, Need AC, Lohoff FW, Zai CC, Chowdhury NI, Müller DJ, Putkonen A, Repo-Tiihonen E, Hallikainen T, Yagcioglu AE, Tiihonen J, Kennedy JL, Meltzer HY. Exome sequence analysis of Finnish patients with clozapine-induced agranulocytosis. Mol Psychiatry 2014:19(4):403-5.
101 Weizmann-Henelius G, Putkonen H, Rissanen T, Eronen M, Webster CD. Exploring a new structured professional judgment measure (impulsivity measure related to violence) after an average follow-up of 10 years: A study of Finnish offenders. Crim Behav Ment Health 2019:29(1):57-68.
102 Miles SW, Sheridan J, Russell B, Kydd R, Wheeler A, Walters C, Gamble G, Hardley P, Jensen M, Kuoppasalmi K, Tuomola P, Föhr J, Kuikanmäki O, Vorma H, Salokangas R, Mikkonen A, Kallio M, Kauhanen J, Kiviniemi V, Tiihonen J. Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial. Addiction 2013:108(7):1279-1286.
103 Uosukainen H, Ilomäki J, Kauhanen J, Tacke U, Föhr J, Tiihonen J, Bell JS. Factors associated with buprenorphine compared to amphetamine abuse among clients seeking treatment in Finland. J Subst Abuse Treat 2014:46(5):561-566.
104 Onyeka IN, Olubamwo O, Beynon CM, Ronkainen K, Förh J, Tiihonen J, Tuomola P, Tasa N, Kauhanen J. Factors Associated with Hospitalization for Blood-Borne Viral Infections Among Treatment-Seeking Illicit Drug Users. J Subst Abuse Treat 2015:53:71-77.
105 Thomson A, Tiihonen J, Miettunen J, Virkkunen M, Lindberg N. Firesetting and general criminal recidivism among a consecutive sample of Finnish pretrial male firesetters: A register-based follow-up study. Psychiatry Res 2018:259:377-384.
106 Thomson A, Tiihonen J, Miettunen J, Virkkunen M, Lindberg N. Fire-setting performed in adolescence or early adulthood predicts schizophrenia: a register-based follow-up study of pre-trial offenders. Nord J Psychiatry 2017:71(2):96-101.
107 Askola R, Nikkonen M, Paavilainen E, Soininen P, Putkonen H, Louheranta O. Forensic Psychiatric Patients' Perspectives on Their Care: A Narrative View. Perspect Psychiatr Care 2018:54(1):64-73.
108 Seppänen A, Joelsson P, Ahlgren-Rimpiläinen A, Repo-Tiihonen E. Forensic psychiatry in Finland: an overview of past, present and future. Int J Ment Health Syst 2020:14:29.
109 Tanskanen A, Taipale H, Koponen M, Tolppanen AM, Hartikainen S, Ahonen R, Tiihonen J. From prescription drug purchases to drug use periods - a second generation method (PRE2DUP). BMC Med Inform Decis Mak 2015:15:21.
110 Tanskanen A1, Taipale H, Koponen M, Tolppanen AM, Hartikainen S, Ahonen R, Tiihonen J. From prescriptions to drug use periods - things to notice. BMC Res Notes 2014:7:796.
111 Tiihonen J, Rautiainen MR, Ollila HM, Repo-Tiihonen E, Virkkunen M, Palotie A, Pietiläinen O, Kristiansson K, Joukamaa M, Lauerma H, Saarela J, Tyni S, Vartiainen H, Paananen J, Goldman D, Paunio T. Genetic background of extreme violent behavior. Mol Psychiatry 2015:20(6):786-92.
112 Tielbeek JJ, Johansson A, Polderman TJ, Rautiainen MR, Jansen P, Taylor M, Tong X, Lu Q, Burt AS, ..., Paunio T, Tiihonen J, ..., Posthuma D. Genome-Wide Association Studies of a Broad Spectrum of Antisocial Behavior. JAMA Psychiatry 2017:74(12):1242-1250.
113 Rautiainen MR, Paunio T, Repo-Tiihonen E, Virkkunen M, Ollila HM, Sulkava S, Jolanki O, Palotie A, Tiihonen J. Genome-wide association study of antisocial personality disorder. Transl Psychiatry 2016:6(9):e883.
114 Tolppanen A-M, Taipale H, Hartikainen S. Head or brain injuries and Alzheimer's disease: A nested case-control register study. Alzheimers Dement 2017:13(12):1371-1379.
115 Taipale H, Rahman S, Tanskanen A, Mehtälä J, Hoti F, Jedenius E, Enkusson D, Leval A, Sermon J, Tiihonen J, Mittendorfer-Rutz E. Health and work disability outcomes in parents of patients with schizophrenia associated with antipsychotic exposure by the offspring. Sci Rep 2020:10(1):1219.
116 Di Thiene D, Rahman S, Helgesson M, Wang M, Alexanderson K, Tiihonen J, La Torre G, Mittendorfer-Rutz E. Healthcare use among immigrants and natives in Sweden on disability pension, before and after changes of regulations. Eur J Public Health 2018:28(3):445-451.
117 Kekkonen V, Kallioniemi E, Kaarre O, Könönen M, Kivimäki P, Gröhn H, Tolmunen T, Vanninen R. Heavy drinking from adolescence to young adulthood is associated with an altered cerebellum. Alcohol 2021:92:35-40.
118 Louheranta O, Lähteenvuo M, Lähteenvuo M, Kangasniemi M. Henkinen ja hengellinen tuki terveydenhuollossa kenen vastuulla? . Sosiaalilääketieteellinen aikakauslehti 2016:53(4):234-241.
119 Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S. High prevalence of psychotropic drug use among persons with and without Alzheimer's disease in Finnish nationwide cohort. Eur Neuropsychopharmacology 2014:24(11):1729-37.
120 Pisa F, Reinold J, Lavikainen P, Koponen M, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A. Hip Fracture Risk in Antiepileptic Drug Initiators and Non-Initiators with Alzheimer's Disease. Clin Epidemiol 2021:13:295-307.
121 Taipale H, Purhonen M, Tolppanen AM, Tanskanen A, Tiihonen J, Hartikainen S. Hospital care and drug costs from five years before until two years after the diagnosis of Alzheimer's disease in a Finnish nationwide cohort. Scand J Public Health 2016:44(2):150-8.
122 Järvinen H, Taipale H, Koponen M, Tanskanen A, Tiihonen J, Tolppanen A-M, Hartikainen S. Hospitalization after oral antibiotic initiation in Finnish community dwellers with and without Alzheimer's disease: retrospective register-based cohort study. J Alzheimer Dis 2018:64(2):437-445.
123 Järvinen H, Taipale H, Koponen M, Tanskanen A, Tiihonen J, Tolppanen A-M, Hartikainen S. Hospitalization after Oral Antibiotic Initiation in Finnish Community Dwellers with and without Alzheimer's Disease: Retrospective Register-Based Cohort Study. J Alzheimer Dis 2018:64(2):437-445.
124 Onyeka IN, Beynon CM, Ronkainen K, Tiihonen J, Föhr J, Kuikanmäki O, Paasolainen M, Kauhanen J. Hospitalization in a cohort seeking treatment for illicit drug use in Finland. J Subst Abuse Treat 2015:53:64-70.
125 Tapiainen V, Hartikainen S, Taipale H, Tiihonen J, Tolppanen A-M. Hospital-treated mental and behavioral disorders and risk of Alzheimer's disease: A nationwide nested case-control study. Eur Psychiatry: J Assoc Eur Psychiatr 2017:43:92-98.
126 Hamina A, Taipale H, Karttunen N, Tanskanen A, Tiihonen J, Tolppanen A, Hartikainen S. Hospital-Treated Pneumonia Associated with Opioid Use Among Community Dwellers with Alzheimer's Disease. J Alzheimer Dis 2019:69(3):807-816.
127 Thomson A, Tiihonen J, Miettunen J, Virkkunen M, Lindberg N, Tiihonen J. Hospital-treated suicide attempts among Finnish fire setters: a follow-up study. Crim Behav Ment Health 2016:26(5):395-402.
128 Kauhanen J, Tiihonen J. Huumeiden terveysriskit Suomessa - voiko niitä hallita? HUUTI-tutkimuksen antia. Duodecim 2017:133(1):34-42.
129 Hamina A, Lavikainen P, Tanskanen A, Tolppanen A-M, Tiihonen J, Hartikainen S, Taipale H. Impact of opioid initiation on antipsychotic and benzodiazepine and related drug use among persons with Alzheimer's disease. Int Psychogeriatr 2018:30(7):947-956.
130 Tikkanen R, Tiihonen J, Rautiainen MR, Paunio T, Bevilacqua L, Panarsky R, Goldman D, Virkkunen M. Impulsive alcohol-related risk-behavior and emotional dysregulation among individuals with a serotonin 2B receptor stop codon. Transl Psychiatry 2015:5:e681.
131 Luykx JJ, Stam N, Tanskanen A, Tiihonen J, Taipale H. In the aftermath of clozapine discontinuation: comparative effectiveness and safety of antipsychotics in patients with schizophrenia who discontinue clozapine. Br J Psychiatry 2020:217(3):498-505.
132 Tiihonen M, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S. Incidence and Duration of Cumulative Bisphosphonate Use among Community-Dwelling Persons with or without Alzheimer's Disease. J Alzheimer Dis 2016:52(1):127-32.
133 Sarycheva T, Taipale H, Lavikainen P, Tiihonen J, Tanskanen A, Hartikainen S, Tolppanen A-M. Incidence and Prevalence of Antiepileptic Medication Use in Community-Dwelling Persons with and without Alzheimer's Disease. J Alzheimer Dis 2018:66(1):387-395.
134 Taipale H, Särkilä H, Tanskanen A, Kurko T, Taiminen T, Tiihonen J, Sund R, Tuulio-Henriksson A, Saastamoinen L, Hietala J. Incidence of and Characteristics Associated With Long-term Benzodiazepine Use in Finland. JAMA Netw Open 2020:3(10):e2019029.
135 Hentilä E, Tiihonen M, Taipale H, Hartikainen S, Tolppanen A. Incidence of antidepressant use among community dwellers with and without Parkinson's disease - a nationwide cohort study. BMC Geriatrics 2021:21(1):202.
136 Puranen A, Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S. Incidence of antidepressant use in community-dwelling persons with and without Alzheimer's disease: 13-year follow-up. Int J Geriatr Psychiatry 2017:32(1):94-101.
137 Koponen M, Tolppanen AM, Taipale H, Tanskanen A, Tiihonen J, Johnell K, Fastbom J, Ahonen R, Hartikainen S. Incidence of antipsychotic use in relation to diagnosis of Alzheimer's disease among community-dwelling persons. Br J Psychiatry 2015:207(5):444-9.
138 Saarelainen L, Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S. The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease. J Alzheimer Dis 2015:49(3):809-18.
139 Saarelainen L, Taipale H, Koponen M, Tanskanen A, Tolppanen A-M, Tiihonen J, Hartikainen S, Tiihonen J, Hartikainen S. The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease. J Alzheimer Dis 2016:49(3):809-18.
140 Ilmaniemi S, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen AM. Incidence of head injury and traumatic brain injury among people with Alzheimer's disease. J Epidemiol Community Health 2019:73(5):451-454.
141 Tanskanen A, Taipale H, Cannon M, Cotter D, Tiihonen J. Incidence of schizophrenia and influence of prenatal and infant exposure to viral infectious diseases. Acta Psychiatr Scand 2021:143(6):487-494.
142 Taipale H, Hamina A, Karttunen N, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A. Incident opioid use and risk of hip fracture among persons with Alzheimer disease: a nationwide matched cohort study. Pain 2019:160(2):417-423.
143 Hyttinen V, Taipale H, Tolppanen A-M, Tanskanen A, Tiihonen J, Hartikainen S, Valtonen H. Incident Use of a Potentially Inappropriate Medication and Hip Fracture in Community-Dwelling Older Persons With Alzheimer's Disease. Ann Pharmacother 2017:51(9):725-734.
144 Laukkanen V, Kärkkäinen O, Kupila J, Kautiainen H, Tiihonen J, Storvik M. Increased metabotropic glutamate 2/3 receptor binding in the perigenual anterior cingulate cortex of cloninger type 2 alcoholics: a whole-hemisphere autoradiography study. Alcohol Alcohol 2015:50(1):62-67.
145 Kärkkäinen O, Häkkinen MR, Auriola S, Kautiainen H, Tiihonen J, Storvik M. Increased steroid hormone dehydroepiandrosterone and pregnenolone levels in post-mortem brain samples of alcoholics. Alcohol 2016:52:63-70.
146 Laukkanen V, Kärkkäinen O, Kautiainen H, Tiihonen J, Storvik M. Increased [³H]quisqualic acid binding density in the dorsal striatum and anterior insula of alcoholics: A post-mortem whole-hemisphere autoradiography study. Psychiatry Res Neuroimaging 2019:287:63-69.
147 Tikkanen R, Saukkonen T, Fex M, Bennet H, Rautiainen MR, Paunio T, Koskinen M, Panarsky R, Bevilacqua L, Sjöberg RL, Tiihonen J, Tiihonen J, Virkkunen M. Influence of a HTR2B stop codon on glucagon homeostasis and glucose excursion in non-diabetic men. Exp Clin Endocrinol Diabetes 2016:124(9):529-534.
148 Kauppila E, Vanninen E, Kaurijoki S, Karhunen L, Pietiläinen KH, Rissanen A, Tiihonen J, Pesonen U, Kaprio J. Influence of serotonin transporter gene polymorphism (5-HTTLPR Polymorphism) on the relation between brain 5-HT transporter binding and heart rate correcrted cardiac repolarization interval. PLoS ONE 2013:8(1):e50303.
149 Wingård L, Taipale H, Reutfors J, Westerlund A, Bodén R, Tiihonen J, Tanskanen A, Andersen M. Initiation and long-term use of benzodiazepines and Z-drugs in bipolar disorder. Bipolar Disord 2018:20(7):634-646.
150 Taipale H, Hamina A, Lampela P, Tanskanen A, Tiihonen J, Karttunen N, Tolppanen A-M, Hartikainen S. Is Alzheimer's Disease Associated with Previous Opioid Use? Pain Med 2018:19(11):2115-2121.
151 Rytkönen M. Kehityskulkuja ja väliintuloja. Ekologinen näkökulma vakavan väkivallanteon tehneiden nuorten sosioemotionaalisen terveyden kehitykseen. Väitöskirja. Kuopio: 2013. Publications of the University of Eastern Finland. Dissertations in Health Sciences 177. 137 s.
152 Keränen T, Kaski M, Scheinin M, Rinne J, Repo-Tiihonen E, Vartiainen H, Halila R, Heinonen S, Halkoaho A, Bendel S, Uusaro A, Turgut T, Roine RO, Launis V, Pasternack A. Kliininen tutkimus erityisryhmille. Kirjassa: Tapani Keränen, Amos Pasternack., toim. Kliinisen tutkimuksen etiikka : opas tutkijoille ja eettisille toimikunnille., s. 62-83. Helsinki: Duodecim, 2015.
153 Purhonen M, Koponen H, Tiihonen J, Tanskanen A. Kun psyykenlääke vain katoaa. Pääkirjoitus. Duodecim 2014:130:438-439.
154 Lavikainen P, Koponen M, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A. Length of Hospital Stay for Hip Fracture and 30-Day Mortality in People With Alzheimer's Disease: A Cohort Study in Finland. J Gerontol A Biol Sci Med Sci 2020:75(11):2184-2192.
155 Pacchiarotti I, Tiihonen J, Kotzalidis GD, Verdolini N, Murru A, Goikolea JM, Valentí M, Aedo A, Vieta E. Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: A systematic review. Eur Neuropsychopharmacology 2019:29(4):457-470.
156 Taipale H, Rysä J, Hukkanen J, Koponen M, Tanskanen A, Tiihonen J, Kröger H, Hartikainen S, Tolppanen A. Long-term thiazide use and risk of low-energy fractures among persons with Alzheimer's disease-nested case-control study. Osteoporos Int 2019:30(7):1481-1489.
157 Koponen M, Taipale H, Tanskanen A, Tolppanen AM, Tiihonen J, Ahonen R, Hartikainen S. Long-term use of antipsychotics among community-dwelling persons with Alzheimer?s disease: A nationwide register-based study. Eur Neuropsychopharmacology 2015:25(10):1706-13.
158 Taipale H, Koponen M, Tanskanen A, Tolppanen A, Tiihonen J, Hartikainen S. Long-term use of benzodiazepines and related drugs among community-dwelling individuals with and without Alzheimer's disease. Int Clin Psychopharmacol 2015:30(4):202-8.
159 Kurko TA, Saastamoinen LK, Tähkäpää S, Tuulio-Henriksson A, Taiminen T, Tiihonen J, Airaksinen MS, Hietala J. Long-term use of benzodiazepines: Definitions, prevalence and usage patterns - a systematic review of register-based studies. Eur Psychiatry: J Assoc Eur Psychiatr 2015:30(8):1037-47.
160 Hamina A, Taipale H, Tanskanen A, Tolppanen A, Karttunen N, Pylkkänen L, Tiihonen J, Hartikainen S. Long-term use of opioids for nonmalignant pain among community-dwelling persons with and without Alzheimer disease in Finland: a nationwide register-based study. Pain 2017:158(2):252-260.
161 Juntunen H, Taipale H, Tanskanen A, Tolppanen A, Tiihonen J, Hartikainen S, Tiihonen M. Long-term use of proton pump inhibitors among community-dwelling persons with and without Alzheimer's disease. Eur J Clin Pharmacol 2017:73(9):1149-1158.
162 Kärkkäinen O, Laukkanen V, Haukijärvi T, Kautiainen H, Tiihonen J, Storvik M. Lower [3H]Citalopram binding in brain areas related to social cognition in alcoholics. Alcohol Alcohol 2015:50(1):46-50.
163 Maron E, Baldwin DS, Balotsev R, ..., Lähteenvuo M, ..., Tiihonen J, et al. Manifesto for an international digital mental health network. Digital Psychiatry 2019:2(1):14-24.
164 Isohanni M, Jääskeläinen E, Miller BJ, Hulkko A, Tiihonen J, Möller H-J, Hartikainen S, Huhtaniska S, Lieslehto J. Medication management of antipsychotic treatment in schizophrenia - a narrative review.
165 Hamina A, Tanskanen A, Tiihonen J, Taipale H. Medication Use and Health Care Utilization After a Cost-sharing Increase in Schizophrenia: A Nationwide Analysis. Med Care 2020:58(9):763-769.
166 Kuokkanen R, Lappalainen R, Repo-Tiihonen E, Tiihonen J. Metacognitive group training for forensic and dangerous non-forensic patients with schizophrenia: A randomised controlled feasibility trial. Crim Behav Ment Health 2014:24(5):345-57.
167 Sluggett JK, Koponen M, Bell JS, Taipale H, Tanskanen A, Tiihonen J, Uusitupa M, Tolppanen A, Hartikainen S. Metformin and Risk of Alzheimer's Disease Among Community-Dwelling People With Diabetes: A National Case-Control Study. J Clin Endocrinol Metab 2020:105(4):dgz234.
168 Kupila J, Kärkkäinen O, Laukkanen V, Tupala E, Tiihonen J, Storvik M. mGluR1/5 receptor densities in the brains of alcoholic subjects: A whole-hemisphere autoradiography study. Psychiatry Res Neuroimaging 2013:212:245-250.
169 Rauhala A, Kinnunen M, Kuosmanen A, Liukka M, Olin K, Sahlström M, Roine RP. Mitä vapaaehtoiset vaaratapahtumailmoitukset kertovat? Suomen Lääkärilehti 2018:73(46):2716-2720.
170 Checknita D, Bendre M, Ekström TJ, Comasco E, Tiihonen J, Hodgins S, Nilsson KW. Monoamine oxidase A genotype and methylation moderate the association of maltreatment and aggressive behaviour. Behav Brain Res 2020:382:112476.
171 Tolppanen A, Ahonen R, Koponen M, Lavikainen P, Purhonen M, Taipale H, Tanskanen A, Tiihonen J, Tiihonen M, Hartikainen S. Month and Season of Birth as a Risk Factor for Alzheimer's Disease: A Nationwide Nested Case-control Study. J Prev Med Public Health 2016:49(2):134-8.
172 Uosukainen H, Kauhanen J, Bell JS, Ronkainen K, Tiihonen J, Föhr J, Onyeka IN, Korhonen MJ. Mortality among clients seeking treatment for buprenorphine abuse in Finland. Drug Alcohol Depend 2013:133:391-397.
173 Ojansuu I, Putkonen H, Tiihonen J. Mortality among forensic psychiatric patients in Finland. Nord J Psychiatry 2015:69(1):25-7.
174 Tiihonen J, Mittendorfer-Rutz E, Torniainen M, Alexanderson K, Tanskanen A. Mortality and Cumulative Exposure to Antipsychotics, Antidepressants, and Benzodiazepines in Patients With Schizophrenia: An Observational Follow-Up Study. Am J Psychiatry 2016:173(6):600-6.
175 Tanskanen A, Tiihonen J, Taipale H. Mortality in schizophrenia: 30-year nationwide follow-up study. Acta Psychiatr Scand 2018:138(6):492-499.
176 Thomson A, Tiihonen J, Miettunen J, Virkkunen M, Lindberg N. Mortality of firesetters: a follow-up study of Finnish male firesetters who underwent a pretrial forensic examination in 1973-1998. Psychiatry Res 2015:225(3):638-42.
177 Lebel JL, Duxbury JA, Putkonen A, Sprague T, Rae C, Sharpe J. Multinational experiences in reducing and preventing the use of restraint and seclusion. J Psychosoc Nurs Ment Health Serv 2014:52(11):22-9.
178 Heikkinen M, Taipale H, Tanskanen A, Mittendorfer-rutz E, Lähteenvuo M, Tiihonen. Naltreksoni vähentää alkoholiongelmaisten sairaalahoitoja. Duodecim 2021:137(4):427.
179 Tiihonen J, Koskuvi M, Lähteenvuo M, Virtanen PL, Ojansuu I, Vaurio O, Gao Y, Hyötyläinen I, Puttonen KA, Repo-Tiihonen E, Paunio T, Rautiainen M, Tyni S, Koistinaho J, Lehtonen S. Neurobiological roots of psychopathy. Mol Psychiatry 2020:25(12):3432-3441.
180 Taipale H, Tolppanen A-M, Tiihonen M, Tanskanen A, Lic P, Tiihonen J, Hartikainen S. No Association Between Proton Pump Inhibitor Use and Risk of Alzheimer's Disease. Am J Gastroenterol 2017:112(12):1802-1808.
181 Tenkanen H, Taskinen H, Kontio R, Repo-Tiihonen E, Tiihonen J, Kinnunen J. Nurses' Time Use in Forensic Psychiatry: Core Interventions Outlined in the Finnish Clinical Practice Guideline on Schizophrenia. J Forensic Nurs 2016:12(2):64-73.
182 Kuosmanen A, Tiihonen J, Repo-Tiihonen E, Eronen M, Turunen H. Nurses' views highlight a need for the systematic development of patient safety culture in forensic psychiatry nursing. J Patient Saf 2021:17(3):e228-e233.
183 Askola R, Louheranta O, Soininen P, Putkonen H, Åstedt-Kurki P, Paavilainen E. The Offense as Perceived by the Parents of Forensic Psychiatric Patients. Issues Ment Health Nurs 2017:38(9):705-711.
184 Tiihonen J. Oikeuspsykiatria. Kirjassa: Lönnqvist J, Henriksson M, Marttunen M, Partonen T, toim. Psykiatria, s. 697-715. Helsinki: Duodecim, 2014.
185 Tiihonen J. Oikeuspsykiatria. Kirjassa: Lönnqvist J, Marttunen M, Henriksson M, Partonen T, toim. Psykiatria, s. pkr02500. Duodecim, 2017.
186 Askola R, Nikkonen M, Vuorio O, Kylmä J. Oikeuspsykiatrisen potilaan toivottomuus ja toivo hoitosuhteessa. Pro terveys 2013(2):20-22.
187 Kivimies K, Repo-Tiihonen E, Kautiainen H, Maaranen P, Muhonen LH, Heikkinen M, Tiihonen J. Opioid abuse and hospitalization rates in patients with schizophrenia. Nord J Psychiatry 2016:70(2):128-32.
188 Lintula E, Tiihonen M, Taipale H, Tolppanen A, Tanskanen A, Tiihonen J, Hartikainen S, Hamina A. Opioid Use After Hospital Care due to Hip Fracture Among Community-Dwelling Persons With and Without Alzheimer's Disease. Drugs Aging 2020:37(3):193-203.
189 Makkonen P, Putkonen A, Korhonen J, Kuosmanen L, Kärkkäinen J. Pakon käytön vähentäminen ja turvallisuuden lisääminen psykiatrisessa hoidossa. Helsinki: Terveydenhuollon ja hyvinvoinnin laitos, 2016. THL Työpaperi 35. 44 s.
190 Kuosmanen L, Laukkanen E. Pakon käytön vähentäminen psykiatrisessa sairaalahoidossa. Duodecim 2019:135(10):925-931.
191 Hipp K, Kuosmanen L, Repo-Tiihonen E, Leinonen M, Louheranta O, Kangasniemi M. Patient participation in pro re nata medication in psychiatric inpatient settings: An integrative review. Int J Ment Health Nurs 2018:27(2):536-554.
192 Kuosmanen A, Tiihonen J, Repo-Tiihonen E, Eronen M, Turunen H. Patient safety culture in two Finnish state-run forensic psychiatric hospitals. J Forensic Nurs 2013:9(4):207-216.
193 Onyeka IN, Beynon CM, Hannila ML, Tiihonen J, Föhr J, Tuomola P, Kuikanmäki O, Tasa N, Paasolainen M, Kauhanen J. Patterns and 14-year trends in mortality among illicit drug users in Finland: the HUUTI study. Int J Drug Policy 2014:25(6):1047-53.
194 Stam N, Taipale H, Tanskanen A, Isphording L, Okhuijsen-Pfeifer C, Schuiling-Veninga CC, Bos JH, Bijker BJ, Tiihonen J, Luykx JJ. Persistence of Antipsychotic Use After Clozapine Discontinuation: A Real-World Study Across Antipsychotics. Clin Transl Sci 2020:13(6):1170-1177.
195 Tiihonen J, Tanskanen A, Hoti F, Vattulainen P, Taipale H, Mehtälä J, Lähteenvuo M. Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study. Lancet Psychiat 2017:4(7):547-553.
196 Kuokkanen R, Aho-Mustonen K, Muotka J, Lappalainen R, Tiihonen J. A Pilot Study of Group Administered Metacognitive Training (MCT) for Schizophrenia Patients in a High-Security Forensic Setting: Subjective Training Success and Health-Related Quality of Life. J Forensic Psychol Pract 2015:15(4):344-362.
197 Jokinen J, Königsson J, Moberg T, Jönsson EG, Tiihonen J, Nordström P, Oreland L, Åsberg M. Platelet monoamine oxidase activity and interpersonal violence in male suicide attempters. Psychiatry Res 2018:260:173-176.
198 Paloneva J, Autti T, Hakola P, Haltia MJ. Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy. In: Adam MP, Ardinger HH, Pagon RA, et al, eds. GeneReviews [Internet], https://www.ncbi.nlm.nih.gov/books/. Seattle (WA), USA: University of Washington, 2020.
199 Onyeka IN, Beynon CM, Vohlonen I, Tiihonen J, Föhr J, Ronkainen K, Kauhanen J. Potential Years of Life Lost Due to Premature Mortality Among Treatment-Seeking Illicit Drug Users in Finland. J Community Health 2015:40(6):1099-106.
200 Stenius J, Knekt P, Heinonen E, Holma J, Antikainen R, Lindfors O. Predicting the working alliance over the course of long-term psychodynamic psychotherapy with the Rorschach Ego Impairment Index, self-reported defense style, and performance-based intelligence: An evaluation of three methodological approaches.
201 Stenberg J-H, Terevnikov V, Joffe M, Tiihonen J, Chukhin E, Burkin M, Joffe G. Predictors and mediators of add-on mirtazapine-induced cognitive enhancement in schizophrenia - A path model investigation. Neuropharmacology 2013:64:248-253.
202 Scheen L, Brandt L, Bodén R, Tiihonen J, Andersen M, Kieler H, Reutfors J. Predictors for initiation of pharmacological prophylaxis in patients with newly diagnosed bipolar disorder - A nationwide cohort study. J Affect Disord 2015:172:204-210.
203 Kalamägi J, Lavikainen P, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A. Predictors of high hospital care and medication costs and cost trajectories in community-dwellers with Alzheimer's disease. Ann Med 2019:51(5):294-305.
204 Vu M, Koponen M, Taipale H, Tanskanen A, Tiihonen J, Kettunen R, Hartikainen S, Tolppanen A. Prevalence of cardiovascular drug use before and after diagnosis of Alzheimer's disease. Int J Cardiol 2020:300:221-225.
205 Taipale H, Vuorikari H, Tanskanen A, Koponen M, Tiihonen J, Kettunen R, Hartikainen S. Prevalence of Drug Combination Increasing Bleeding Risk Among Warfarin Users With and Without Alzheimer’s Disease. Drugs Aging 2015:32(11):937-45.
206 Kivimies K, Repo-Tiihonen E, Kautiainen H, Tiihonen J. Previous forensic mental examination is a useful marker indicating effective violence relapse prevention among psychotic patients. Nord J Psychiatry 2014:68(5):311-5.
207 Hipp K, Repo-Tiihonen E, Kuosmanen L, Katajisto J, Kangasniemi M. PRN medication events in a forensic psychiatric hospital: a document analysis of the prevalence and reasons. Int J Forensic Ment Health 2020:19(4):329-340.
208 Koskinen L1, Likitalo H, Aho J, Vuorio O, Meretoja R. The professional competence profile of Finnish nurses practising in a forensic setting. J Psychiatr Mental Health Nurs 2014:21(4):320-6.
209 Hallikainen I, Martikainen J, Lin PJ, Cohen J T, Lahoz R, Välimäki T, Hongisto K, Väätäinen S, Vanhanen M, Neumann P J, Hänninen T, Koivisto AM. The Progression of Alzheimer's Disease Can Be Assessed with a Short Version of the CERAD Neuropsychological Battery: The Kuopio ALSOVA Study. Dement Geriatr Cogn Disord Extra 2014(4):494-508.
210 Torvinen-Kiiskinen S, Tolppanen A-M, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Taipale H. Proton pump inhibitor use and risk of hip fractures among community-dwelling persons with Alzheimer's disease-a nested case-control study. Aliment Pharmacol Ther 2018:47(8):1135-1142.
211 Laukkanen E, Kuosmanen L, Louheranta O, Vehviläinen-Julkunen K. Psychiatric nursing managers' attitudes towards containment methods in psychiatric inpatient care. J Nurs Manag 2020:28(3):699-709.
212 Laukkanen E, Vehviläinen-Julkunen K, Louheranta O, Kuosmanen L. Psychiatric nursing staffs' attitudes towards the use of containment methods in psychiatric inpatient care: An integrative review. Int J Ment Health Nurs 2019:28(2):390-406.
213 Thomson A, Tiihonen J, Miettunen J, Sailas E, Virkkunen M, Lindberg N. Psychopathic traits among a consecutive sample of Finnish pretrial fire-setting offenders. BMC Psychiatry 2015:15:44.
214 Vaurio O, Repo-Tiihonen E, Kautiainen H, Tiihonen J. Psychopathy and Mortality. J Forensic Sci 2018:63(2):474-477.
215 Lähteenvuo M, Antolin-Concha D, Vattulainen P, Tanskanen A, Taipale H, Tiihonen J. Psychopharmacological treatment, mortality and suicide in bipolar disorder in a Finnish nationwide cohort of 18,018 patients. Psychiatr Fenn 2018:49:10-21.
216 Rubio JM, Taipale H, Correll CU, Tanskanen A, Kane JM, Tiihonen J. Psychosis breakthrough on antipsychotic maintenance: results from a nationwide study. Psychol Med 2020:50(8):1356-1367.
217 Rubio JM, Schoretsanitis G, John M, Tiihonen J, Taipale H, Guinart D, Malhotra AK, Correll CU, Kane JM. Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis. Lancet Psychiat 2020:7(9):749-761.
218 Tiihonen J, Lehti M, Aaltonen M, Kivivuori J, Kautiainen H, Virta L, Hoti F, Tanskanen A, Korhonen P. Psychotropic drugs and homicide: A prospective cohort study from Finland. World Psychiatry 2015:14(2):245-247.
219 Orsel K, Taipale H, Tolppanen A-M, Koponen M, Tanskanen A, Tiihonen J, Gardarsdottir H, Hartikainen S. Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer's disease. Eur Neuropsychopharmacology 2018:28(11):1260-1269.
220 Tiihonen J, Mittendorfer-rutz E, Majak M, Mehtälä J, Hoti F, Jedenius E, Enkusson D, Leval A, Sermon J, Tanskanen A, Taipale H. Psykoosilääkityksen vaikuttavuus skitsofrenian hoidossa. Duodecim 2017:133(15):1412.
221 Liehu M, Tiihonen M, Taipale H, Tanskanen A, Tiihonen J, Tolppanen A-M, Hartikainen S, Koponen M. Psykoosilääkkeiden käyttö on pitkäkestoista Alzheimerin tautia sairastavilla. Dosis 2020:2020(36):6-23.
222 Hallikainen T, Repo-Tiihonen E. Psykoottisen potilaan aggressio - ehkäisy ja hoito. Duodecim 2015:131(15):1361-6.
223 Kettunen R, Suvisaari J, Tiihonen J, Ruskoaho H, Huikuri H. Psyykenlääkkeet ja sydän. Duodecim 2020:136(2):1411-8.
224 Kuosmanen A, Liukka M, Aaltonen L-M, Roine RP, Kinnunen M. Pääsyy vai syypää - potilasturvallisuuskulttuuri ratkaisee. Suomen Lääkärilehti 2018:73(8):518-519.
225 Tiihonen J, Mittendorfer-Rutz E, Majak M, Mehtälä J, Hoti F, Jedenius E, Enkusson D, Leval A, Sermon J, Tanskanen A, Taipale H. Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29?823 Patients With Schizophrenia. JAMA Psychiatry 2017:74(7):686-693.
226 Tiihonen J, Tiihonen J. Real-world effectiveness of antipsychotics. Editorial. Acta Psychiatr Scand 2016:134(5):371-373.
227 Lähteenvuo M, Tanskanen A, Taipale H, Hoti F, Vattulainen P, Vieta E, Tiihonen J. Real-world effectiveness of pharmacologic treatments for the prevention of rehospitalization in a Finnish nationwide cohort of patients with bipolar disorder. JAMA Psychiatry 2018:75(4):347-355.
228 Putkonen A. Recovery From Cervical Dystonia With Topiramate. J Med Cases 2015:6(8):373-375.
229 Wingård L, Bodén R, Brandt L, Tiihonen J, Tanskanen A, Kieler H, Andersen M, Reutfors J. Reducing the rehospitalization risk after a manic episode: A population based cohort study of lithium, valproate, olanzapine, quetiapine and aripiprazole in monotherapy and combinations. J Affect Disord 2017:217:16-23.
230 Tuovinen S. Reduction of Seclusion and Restraint and Hospital Violence During Involuntary Forensic Psychiatric Care. Doctoral dissertation. Kuopio: UEF, 2017. Publications of the University of Eastern Finland. Dissertations in Health Sciences 446. 54., append.
231 Tolppanen A, Voutilainen A, Taipale H, Tanskanen A, Lavikainen P, Koponen M, Tiihonen J, Hartikainen S. Regional changes in psychotropic use among Finnish persons with newly diagnosed Alzheimer's disease in 2005-2011. PLoS ONE 2017:12(3):e0173450.
232 Taipale H, Tiihonen J. Registry-based studies: What they can tell us, and what they cannot. PPPP 2021:45:35-37.
233 Tiihonen J, Taipale H, Correll CU. Rejoinder to rejoinder to commentary. Psychol Med 2020:50(16):2812-2813.
234 Terevnikov V, Stenberg J-H, Tiihonen J, Chukhin E, Joffe M, Burkin M, Joffe G. Relationships between pharmacotherapy-induced metabolic changes and improved psychopathology in schizophrenia: data from a mirtazapine and first-genedation antipsychotics combination trial. Int J Neuropsychopharmacol 2013:16:1661-1666.
235 Kallioniemi E, Kärkkäinen O, Määttä S, Könönen M, Kivimäki P, Kaarre O, Velagapudi V, Kekkonen V, Lehto SM, Laukkanen E, Tolmunen T. Repeated Transcranial Magnetic Stimulation-Induced Motor Evoked Potentials Correlate With the Subject-Specific Serum Metabolic Profile of Creatine. J Clin Neurophysiol 2019:36(3):229-235.
236 Tiihonen J. Response to the editorial on antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia. Schizophr Res 2018:202:397.
237 Taipale H, Reutfors J, Tanskanen A, Brandt L, Tiihonen J, DiBernardo A, Mittendorfer-Rutz E, Brenner P. Risk and risk factors for disability pension among patients with treatment resistant depression- a matched cohort study. BMC Psychiatry 2020:20(1):232.
238 Hyttinen V, Taipale H, Tanskanen A, Tiihonen J, Tolppanen AM, Hartikainen S, Valtonen H. Risk Factors for Initiation of Potentially Inappropriate Medications in Community-Dwelling Older Adults with and without Alzheimer's Disease. Drugs Aging 2017:34(1):67-77.
239 Imtiaz B, Taipale H, Tanskanen A, Tiihonen M, Kivipelto M, Heikkinen A, Tiihonen J, Soininen H, Hartikainen S, Tolppanen A. Risk of Alzheimer's disease among users of postmenopausal hormone therapy: A nationwide case-control study. Maturitas 2017:98:7-13.
240 Tapiainen V, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A-M. The risk of Alzheimer's disease associated with benzodiazepines and related drugs: a nested case-control study. Acta Psychiatr Scand 2018:138(2):91-100.
241 Saarelainen L, Tolppanen A-M, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Taipale H. Risk of death associated with new benzodiazepine use among persons with Alzheimer disease: A matched cohort study. Int J Geriatr Psychiatry 2018:33(4):583-590.
242 Di Thiene D, Helgesson M, Alexanderson K, La Torre G, Tiihonen J, Mittendorfer-Rutz E. Risk of disability pension in first and second generation immigrants: the role of age and region of birth in a prospective population-based study from Sweden. BMC Public Health 2017:17(1):931.
243 Taipale H, Koponen M, Tanskanen A, Lavikainen P, Sund R, Tiihonen J, Hartikainen S, Tolppanen A. Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer's disease: a nationwide matched cohort study. Alzheimers Res Ther 2017:9(1):59.
244 Tapiainen V, Lavikainen P, Koponen M, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A. The Risk of Head Injuries Associated With Antipsychotic Use Among Persons With Alzheimer's disease. J Am Geriatr Soc 2020:68(3):595-602.
245 Saarelainen L, Tolppanen A-M, Koponen M, Tanskanen A, Sund R, Tiihonen J, Hartikainen S, Taipale H. Risk of Hip Fracture in Benzodiazepine Users With and Without Alzheimer Disease. J Am Med Dir Assoc 2017:18(1):87.e15-87.e21.
246 Di THIENE D, Helgesson M, Rahman S, Alexanderson K, Tiihonen J, la TORRE G, Mittendorfer-rutz E. Risk of labour market marginalisation among young refugees and non-refugee migrants with common mental disorders. Soc Psychiatry Psychiatr Epidemiol 2021:56(6):1025-1034.
247 Koponen M, Taipale H, Lavikainen P, Tanskanen A, Tiihonen J, Tolppanen AM, Ahonen R, Hartikainen S. Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease. J Alzheimer Dis 2017:56(1):107-118.
248 Taipale H, Tolppanen A, Koponen M, Tanskanen A, Lavikainen P, Sund R, Tiihonen J, Hartikainen S. Risk of pneumonia associated with incident benzodiazepine use among community-dwelling adults with Alzheimer disease. Can Med Assoc J 2017:189(14):E519-E529.
249 Tiihonen J, Tanskanen A, Taipale H. Risk of Treatment Failure: Response to Czobor and Volavka. Am J Psychiatry 2018:175(9):909.
250 Tolppanen A-M, Taipale H, Koponen M, Tanskanen A, Lavikainen P, Paananen J, Tiihonen J, Hartikainen S. Screening approach for identifying candidate drugs and drug-drug interactions related to hip fracture risk in persons with Alzheimer disease. Pharmacoepidemiol Drug Saf 2017:26(8):875-889.
251 Kuivalainen S, Vehviläinen-Julkunen K, Louheranta O, Putkonen A, Repo-Tiihonen E, Tiihonen J. Seasonal variation of hospital violence, seclusion and restraint in a forensic psychiatric hospital. Int J Law Psychiatry 2017:52:1-6.
252 Laukkanen E, Kuosmanen L, Selander T, Vehviläinen-Julkunen K. Seclusion, restraint, and involuntary medication in Finnish psychiatric care: a register study with root-level data. Nord J Psychiatry 2020:74(6):439-443.
253 Joensuu M. Serotonin transporter availability in major depression. Single photon emission tomography studies on drug-naïve depressed subjects: comparison with healthy subjects, effect of genotype, and follow-up during psychodynamic psychotherapy. Doctoral dissertation. Kuopio: University of Eastern Finland, 2019. Publications of the University of Eastern Finland. Dissertations in Health Sciences 513. 74 p.
254 Tiihonen J, Koskuvi M, Storvik M, Hyötyläinen I, Gao Y, Puttonen KA, Giniatullina R, Poguzhelskaya E, Ojansuu I, Vaurio O, Cannon TD, Lönnqvist J, Therman S, Suvisaari J, Kaprio J, Cheng L, Hill AF, Lähteenvuo M, et al. Sex-specific transcriptional and proteomic signatures in schizophrenia. Nat Commun 2019:10(1):3933.
255 Tuppurainen H, Kivistö P, Repo-Tiihonen E, Tiihonen J. Skitsofrenian Käypä hoito -suosituksen toteutuminen Niuvanniemen sairaalassa. Suomen Lääkärilehti 2014:69(40):2549-2553.
256 Tiihonen J. Skitsofrenian lääkehoito. Duodecim 2019:135(20):2021-7.
257 Ojansuu I, Putkonen H, Lähteenvuo M, Tiihonen J. Substance Abuse and Excessive Mortality Among Forensic Psychiatric Patients: A Finnish Nationwide Cohort Study. Front Psychiatry 2019:10:678.
258 Antolín-Concha D, Lähteenvuo M, Vattulainen P, Tanskanen A, Taipale H, Vieta E, Tiihonen J. Suicide mortality and use of psychotropic drugs in patients hospitalized due to bipolar disorder: A Finnish nationwide cohort study. J Affect Disord 2020:277:885-892.
259 Johanson M, Vaurio O, Tiihonen J, Lähteenvuo M. A Systematic Literature Review of Neuroimaging of Psychopathic Traits. Front Psychiatry 2020:10:1027.
260 Tolppanen A-M, Tiihonen M, Taipale H, Koponen M, Tanskanen A, Lavikainen P, Tiihonen J, Hartikainen S. Systemic Estrogen Use and Discontinuation After Alzheimer's Disease Diagnosis in Finland 2005-2012: A Nationwide Exposure-Matched Cohort Study. Drugs Aging 2018:35(11):985-992.
261 Tolmunen T, Suonmaa E, Ruusunen A, Voutilainen S, Lehto S. Tehoavatko omega-3-rasvahapot nuorten mielenterveys- ja oppimishäiriöihin? Suomen Lääkärilehti 2015:70(41):2695-2701.
262 Askola R, Nikkonen M, Putkonen H, Kylmä J, Louheranta O. The Therapeutic Approach to a Patient's Criminal Offense in a Forensic Mental Health Nurse-Patient Relationship-The Nurses' Perspectives. Perspect Psychiatr Care 2017:53(3):164-174.
263 Lehtonen J, Tiihonen J, Joensuu MMO, Lehto SM, Ahola PO, Saarinen PI, Valkonen-Korhonen M, Tolmunen T, Kuikka JT. Toward molecular psychotherapy of depression? In: Levy RA, Ablon JS, Kächele H, eds. Psychodynamic Psychotherapy Research, p. 219-232. New York: Springer, 2012.
264 Wang M, Vaez M, Dorner TE, Tiihonen J, Voss M, Ivert T, Mittendorfer-Rutz E. Trajectories and characteristics of work disability before and after acute myocardial infarction. Heart 2018:104(4):340-348.
265 Di Thiene D, Mittendorfer-Rutz E, Rahman S, Wang M, Alexanderson K, Tiihonen J, La Torre G, Helgesson M. Trajectories of sickness absence, disability pension and unemployment in young immigrants with common mental disorders. Eur J Public Health 2019:29(6):1055-1062.
266 Kurko T, Saastamoinen LK, Tuulio-Henriksson A, Taiminen T, Tiihonen J, Airaksinen M, Hietala J. Trends in the long-term use of benzodiazepine anxiolytics and hypnotics: A national register study for 2006 to 2014. Pharmacoepidemiol Drug Saf 2018:27(6):674-682.
267 Uosukainen H, Kauhanen J, Voutilainen S, Föhr J, Paasolainen M, Tiihonen J, Laitinen K, Onyeka IN, Bell JS. Twelve-year trend in treatment seeking for buprenorphine abuse in Finland. Drug Alcohol Depend 2013:127:207-214.
268 Lampela P, Tolppanen AM, Tanskanen A, Tiihonen J, Lavikainen P, Hartikainen S, Taipale H. Use of antidementia drugs and risk of pneumonia in older persons with Alzheimer's disease. Ann Med 2017:49(3):230-239.
269 Puranen A, Koponen M, Tanskanen A, Tiihonen J, Taipale H. Use of antidepressants and mood stabilizers in persons with first-episode schizophrenia. Eur J Clin Pharmacol 2020:76(5):711-718.
270 Taipale H, Gomm W, Broich K, Maier W, Tolppanen A-M, Tanskanen A, Tiihonen J, Hartikainen S, Haenisch B. Use of Antiepileptic Drugs and Dementia Risk-an Analysis of Finnish Health Register and German Health Insurance Data. J Am Geriatr Soc 2018:66(6):1123-1129.
271 Taipale H, Koponen M, Tanskanen A, Lavikainen P, Tolppanen AM, Sund R, Tiihonen J, Hartikainen S. Use of benzodiazepines and related drugs is associated with a risk of stroke among persons with Alzheimer's disease. Int Clin Psychopharmacol 2017:32(3):135-141.
272 Asikainen J, Louheranta O, Vehviläinen-Julkunen K, Repo-Tiihonen E. Use of coercion prevention tools in Finnish psychiatric wards. Arch Psychiatr Nurs 2020:34(5):412-420.
273 Tolppanen A-M, Taipale H, Koponen M, Lavikainen P, Tanskanen A, Tiihonen J, Hartikainen S. Use of existing data sources in clinical epidemiology: Finnish health care registers in Alzheimer's disease research - the Medication use among persons with Alzheimer's disease (MEDALZ-2005) study. Clin Epidemiol 2013:5:277-285.
274 Tiihonen J. Use of lithium in patients with unipolar depression - Author's reply. Lancet Psychiat 2017:4(9):663.
275 Michel SF, Riaz M, Webster C, Hart SD, Levander S, Müller-Isberner R, Tiihonen J, Repo-Tiihonen E, Tuninger E, Hodgins S. Using the HCR-20 to predict aggressive behavior among men with schizophrenia living in the community: Accuracy of prediction, general and forensic settings, and dynamic risk factors. Int J Forensic Ment Health 2013:12(1):1-13.
276 Ahlgrén-Rimpiläinen A, Joelsson P, Kaarre H, Rautanen M, Niinistö K, Lindberg N, Tiihonen J. Vaarallisuuden arviointi - sattuman summaako. Edilex 2020:41:1-30.
277 Repo-Tiihonen E. Vaikeaa psykiatrista sairautta sairastavat ja oikeuspsykiatriset potilaat. Kirjassa: Keränen Tapani, Amos Pasternack, toim. Kliinisen tutkimuksen etiikka: opas tutkijoille ja eettisille toimikunnille, s. 70-73. Helsinki: Duodecim, 2015.
278 Lindeman S, Kolari T, Tiihonen J. Valproate and Neuroleptic Malignant Syndrome in an Elderly Patient With Schizoaffective Disorder. Prim Care Companion CNS Disord 2020:22(3):19/02542.
279 Asikainen J, Vehviläinen-Julkunen K, Repo-Tiihonen E, Louheranta O. Violence factors and debriefing in psychiatric inpatient care: A Review . J Psychosoc Nurs Ment Health Serv 2020:58(5):39-49.
280 Kuivalainen S, Vehviläinen-Julkunen K, Putkonen A, Louheranta O, Tiihonen J. Violent behaviour in a forensic psychiatric hospital in Finland: an analysis of violence incident reports. J Psychiatr Mental Health Nurs 2014:21(3):214-8.
281 Tiihonen J. Voisiko luonnon oma säilöntäaine mullistaa psykoosin hoidon? Pääkirjoitus. Duodecim 2013:129:2098-2099.
282 Rossi R, Pievani M, Järvenpää T, Testa C, Koskenvuo M, Räihä I, Kaprio J, Frisoni GB, Rinne JO, Laakso MP, Laakso MP. Voxel-based morphometry study on monozygotic twins discordant for Alzheimer's disease. Acta Neurol Scand 2016:133(6):427-33.
283 Lindner P, Budhiraja M, Westerman J, Savic I, Jokinen J, Tiihonen J, Hodgins S. White matter correlates of psychopathic traits in a female community sample. Soc Cogn Affect Neurosci 2017:12(9):1500-1510.
284 Vanhanen M, Hakola P, Ilonen T, Tiihonen J. Word list learning in patients with polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy. Dement Geriatr Cogn Disord 2013:3:10-15.

Julkaisutietokanta 25.7.2021 Publications Data Base 25.7.2021